4//SEC Filing
Gullans Steven R. Ph.D. 4
Accession 0001596771-18-000053
CIK 0001638287other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:32 PM ET
Size
5.7 KB
Accession
0001596771-18-000053
Insider Transaction Report
Form 4
Gullans Steven R. Ph.D.
Director
Transactions
- Award
Employee Stock Option (right to buy)
2018-05-01+150,000→ 150,000 totalExercise: $5.56Exp: 2028-04-30→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]The option vests in a series of 48 successive equal monthly installments on the last day of each month, commencing on the grant date. The option includes an early exercise provision, subject to the issuer's right of repurchase with respect to any unvested shares of common stock.
- [F2]The reporting person ceased to be a manager of Excel Venture Fund II, L.P. on May 1, 2018 and will no longer report beneficial ownership of the issuer's securities owned by such entity.
Documents
Issuer
Gemphire Therapeutics Inc.
CIK 0001638287
Entity typeother
Related Parties
1- filerCIK 0001571997
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 4:32 PM ET
- Size
- 5.7 KB